Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19
dc.contributor.author | Sacco , Keith | |
dc.contributor.author | Castagnoli , Riccardo | |
dc.contributor.author | Vakkilainen, Svetlana | |
dc.contributor.author | Liu, Can | |
dc.contributor.author | Delmonte, Ottavia M. | |
dc.contributor.author | Oguz, Cihan | |
dc.contributor.author | Kaplan, Ian M. | |
dc.contributor.author | Alehashemi, Sara | |
dc.contributor.author | Burbelo, Peter D. | |
dc.contributor.author | Bhuyan, Farzana | |
dc.contributor.author | Jesus, Adriana A. | |
dc.contributor.author | Dobbs , Kerry | |
dc.contributor.author | Rosen, Lindsey B. | |
dc.contributor.author | Cheng, Aristine | |
dc.contributor.author | Shaw, Elana | |
dc.contributor.author | Vakkilainen, Mikko S. | |
dc.contributor.author | Pala , Francesca | |
dc.contributor.author | Lack, Justin | |
dc.contributor.author | Zhang, Yu | |
dc.contributor.author | Fink, Danielle L. | |
dc.contributor.author | Oikonomou, Vasileios | |
dc.contributor.author | Snow , Andrew L. | |
dc.contributor.author | Dalgard, Clifton L. | |
dc.contributor.author | Chen, Jinguo | |
dc.contributor.author | Sellers, Brian A. | |
dc.contributor.author | Montealegre Sanchez, Gina A. | |
dc.contributor.author | Barron, Karyl | |
dc.contributor.author | Rey-Jurado, Emma | |
dc.contributor.author | Vial, Cecilia | |
dc.contributor.author | Poli, Cecilia | |
dc.contributor.author | Licari, Amelia | |
dc.contributor.author | Montagna, Daniela | |
dc.contributor.author | Marseglia, Gian Luigi | |
dc.date.accessioned | 2022-04-06T20:39:33Z | |
dc.date.available | 2022-04-06T20:39:33Z | |
dc.date.issued | 2022 | |
dc.description | Francesco Licciardi; Ugo Ramenghi; Valentina Discepolo; Andrea Lo Vecchio; Alfredo Guarino; Eli M. Eisenstein; Luisa Imberti ; Alessandra Sottini; Andrea Biondi; Sayonara Mató; Dana Gerstbacher; Meng Truong; Michael A. Stack; Mary Magliocco; Marita Bosticardo; Tomoki Kawai; Jeffrey J. Danielson; Tyler Hulett; Manor Askenazi; Shaohui Hu; NIAID Immune Response to COVID Group*; Chile MIS-C Group*; Pavia Pediatric; COVID-19 Group*; Jeffrey I. Cohen; Helen C. Su ; Douglas B. Kuhns; Michail S. Lionakis Thomas M. Snyder; Steven M. Holland; Raphaela Goldbach-Mansky; John S. Tsang and Luigi D. Notarangelo | es |
dc.description.abstract | Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers, proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n= 110) and MIS-C (n= 76), along with pediatric healthy controls (pHCs; n= 76). pCOVID-19 was characterized by robust type I interferon (IFN) responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy | es |
dc.description.version | Versión Publicada | es |
dc.identifier.citation | Sacco, K., Castagnoli, R., Vakkilainen, S. et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med (2022). https://doi.org/10.1038/s41591-022-01724-3 | es |
dc.identifier.uri | https://doi.org/10.1038/s41591-022-01724-3 | es |
dc.identifier.uri | http://hdl.handle.net/11447/5952 | |
dc.language.iso | en | es |
dc.subject | Immunopathogenesis | es |
dc.subject | Inflammation | es |
dc.subject | RNA sequencing | es |
dc.subject | SARS-CoV-2 | es |
dc.subject | Viral infection | es |
dc.title | Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 | es |
dc.type | Article | es |
dcterms.source | Nature Medicine | es |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Sacco et al Immunopathological signatures in MIS-C.pdf
- Size:
- 12.73 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: